Estate Counselors LLC Acquires Shares of 13,678 Cigna Group $CI

Key Points

• Estate Counselors LLC acquired a new stake of 13,678 shares in Cigna Group (NYSE:CI) during Q4, valued at about $3.77 million.
• Cigna beat Q1 estimates (EPS $7.79 vs. $7.60; revenue $68.52B vs. $66.29B) and raised FY2026 adjusted EPS guidance to $30.35, while analysts show a consensus "Moderate Buy" and a consensus price target of $336.20.
• The company announced a quarterly dividend of $1.56 per share (annualized $6.24, ~2.2% yield; ex‑dividend June 4), with roughly 86.99% of shares held by institutions and modest insider selling leaving insiders owning about 0.6%.

Estate Counselors LLC acquired a new stake in Cigna Group (NYSE:CI - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 13,678 shares of the health services provider's stock, valued at approximately $3,765,000.

A number of other large investors also recently modified their holdings of CI. Capital Research Global Investors increased its position in shares of Cigna Group by 140.2% in the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider's stock valued at $916,434,000 after purchasing an additional 1,855,897 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in shares of Cigna Group by 8.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider's stock valued at $3,249,113,000 after buying an additional 903,334 shares in the last quarter. Ameriprise Financial Inc. boosted its holdings in shares of Cigna Group by 54.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider's stock valued at $615,781,000 after buying an additional 753,865 shares in the last quarter. M&T Bank Corp boosted its holdings in shares of Cigna Group by 1,299.3% in the 4th quarter. M&T Bank Corp now owns 635,706 shares of the health services provider's stock valued at $174,965,000 after buying an additional 590,277 shares in the last quarter. Finally, Vanguard Group Inc. boosted its holdings in shares of Cigna Group by 1.6% in the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider's stock valued at $7,203,754,000 after buying an additional 414,834 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CI. Zacks Research upgraded shares of Cigna Group from a "strong sell" rating to a "hold" rating in a report on Monday, January 5th. Cantor Fitzgerald upped their target price on shares of Cigna Group from $325.00 to $340.00 and gave the company an "overweight" rating in a report on Friday. Jefferies Financial Group lowered their target price on shares of Cigna Group from $333.00 to $330.00 and set a "buy" rating for the company in a report on Monday, April 20th. UBS Group restated a "buy" rating and issued a $375.00 target price on shares of Cigna Group in a report on Monday, February 9th. Finally, Leerink Partners upped their target price on shares of Cigna Group from $270.00 to $297.00 and gave the company a "market perform" rating in a report on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $336.20.

Cigna Group Stock Up 0.1%

Shares of NYSE:CI opened at $283.14 on Monday. The stock has a market cap of $74.62 billion, a P/E ratio of 12.00, a P/E/G ratio of 0.98 and a beta of 0.30. The firm has a fifty day moving average price of $274.34 and a 200 day moving average price of $276.63. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts' consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion during the quarter, compared to analysts' expectations of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. Cigna Group's quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts predict that Cigna Group will post 30.41 EPS for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group's dividend payout ratio is presently 28.13%.

Insiders Place Their Bets

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the company's stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the company's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider owned 32,647 shares of the company's stock, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by corporate insiders.

Trending Headlines about Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
• Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an "outperform" rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
• Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
• Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
• Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
• Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
• Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

Cigna Group Company Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.